BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 7874192)

  • 1. Cancer surveillance during HRT.
    Palacios S
    Int J Fertil Menopausal Stud; 1994; 39 Suppl 2():93-8. PubMed ID: 7874192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of HRT and the subsequent risk of cancer.
    Beral V; Banks E; Reeves G; Appleby P
    J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hormone replacement therapy and cancer].
    Bjørge T; Tropé C
    Tidsskr Nor Laegeforen; 1997 Jun; 117(15):2201-7. PubMed ID: 9235712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does HRT modify risk of gynecological cancers?
    Schneider HP; Birkhauser M
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():40-53. PubMed ID: 7581588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer issues.
    Marsden J; Sturdee D
    Best Pract Res Clin Obstet Gynaecol; 2009 Feb; 23(1):87-107. PubMed ID: 19036643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are women with breast, endometrial, or ovarian cancer at increased risk for colorectal cancer?
    Schoen RE; Weissfeld JL; Kuller LH
    Am J Gastroenterol; 1994 Jun; 89(6):835-42. PubMed ID: 8198091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hormone replacement therapy and cancer of the breast. 1. Does replacement therapy increase the risk of cancer of the breast?].
    Ayres de Campos D; Barros H; Martinez de Oliveira J
    Acta Med Port; 1997 Oct; 10(10):697-703. PubMed ID: 9477595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex steroids and breast cancer prevention.
    Spicer DV; Pike MC
    J Natl Cancer Inst Monogr; 1994; (16):139-47. PubMed ID: 7999456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of gynecological cancers in users of estradiol/dydrogesterone or other HRT preparations.
    Schneider C; Jick SS; Meier CR
    Climacteric; 2009 Dec; 12(6):514-24. PubMed ID: 19905903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for gynecologic cancer. Vulvar, vaginal, endometrial, and ovarian neoplasms.
    Hall KL; Dewar MA; Perchalski J
    Prim Care; 1992 Sep; 19(3):607-20. PubMed ID: 1410066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Do sex steroids cause breast and genital cancers? Epidemiologic data--the current status (July 1993)].
    Beller FK
    Geburtshilfe Frauenheilkd; 1993 Oct; 53(10):657-66. PubMed ID: 8270146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormone replacement therapy and breast cancer risk.
    Gambrell RD
    S Afr J Surg; 1996 Nov; 34(4):169-73; discussion 173-4. PubMed ID: 9015939
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cancer risk under hormone therapy].
    Lauritzen C
    Ther Umsch; 1994 Nov; 51(11):755-66. PubMed ID: 7839334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of mammography and risk of developing breast cancer in patients with ovarian or endometrial cancer].
    Ietimalar H; Koksal A; Chelik N; Kasap B; Chukurova K; Iuldarum A
    Akush Ginekol (Sofiia); 2009; 48(5):23-30. PubMed ID: 20198794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic analysis of breast and gynecologic cancers.
    Hulka BS
    Prog Clin Biol Res; 1997; 396():17-29. PubMed ID: 9108587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Breast density: a major parameter to follow during hormone replacement therapy].
    Gairard B; Guldenfels C; Haehnel P; Mathelin C
    Gynecol Obstet Fertil; 2009; 37(7-8):657-60. PubMed ID: 19577502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is HRT justified for symptom management in women at higher risk of developing breast cancer?
    Rippy L; Marsden J
    Climacteric; 2006 Dec; 9(6):404-15. PubMed ID: 17085372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.